US health regulators make it easier to sell devices that position brain implants

The US Food and Drug Administration is reclassifying a specific type of medical device to a lower risk category. This means manufacturers will face fewer regulatory hurdles to bring these devices to market.

For years, new medical devices faced a long and expensive approval process, even for components that posed little risk. This change means that a device used to position a brain implant, but not the implant itself, can now be approved much faster. It signals a shift towards faster approval for low-risk components of complex medical systems.